Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPublications are described as auto-filled from PubMed in the Publications section. The revision tag now shows version v3.3.2, replacing the previous v3.2.0 description.SummaryDifference0.1%

- Check22 days agoChange DetectedThe government funding/operating status notice was removed from the page. Core study details, eligibility criteria, and contacts remain unchanged.SummaryDifference0.4%

- Check36 days agoChange DetectedThe update appears to include non-substantive changes such as updated Study Record Dates and minor formatting; core study content (interventions, eligibility criteria, endpoints) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedCore content updated: adds a funding-lapse notice with open status for the NIH Clinical Center and directs to status sites; replaces version v3.1.0 with v3.2.0.SummaryDifference3%

- Check72 days agoChange DetectedUpdates add new date/version metadata (2025-09-22, 2025-09-18, Last Update Posted (Estimated), Revision: v3.1.0) and remove several older cancer-related topics (e.g., Ovarian cancer, Carcinoma, Neoplasms) leading to a narrowed content focus.SummaryDifference1%

- Check87 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' control was removed, which is a UI change and does not affect core content.SummaryDifference0.2%

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.